106 related articles for article (PubMed ID: 31648168)
1. In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1.
Sanasam BD; Kumar S
Mol Immunol; 2019 Dec; 116():131-139. PubMed ID: 31648168
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum.
Pritam M; Singh G; Swaroop S; Singh AK; Singh SP
BMC Bioinformatics; 2019 Feb; 19(Suppl 13):468. PubMed ID: 30717656
[TBL] [Abstract][Full Text] [Related]
3. Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse
Noe AR; Terry FE; Schanen BC; Sassano E; Hindocha P; Phares TW; Moise L; Christen JM; Tucker KD; Kotraiah V; Drake DR; Martin WD; De Groot AS; Gutierrez GM
Front Immunol; 2021; 12():689920. PubMed ID: 34168657
[TBL] [Abstract][Full Text] [Related]
4. In-silico screening, identification and validation of a novel vaccine candidate in the fight against Plasmodium falciparum.
Panda SK; Mahapatra RK
Parasitol Res; 2017 Apr; 116(4):1293-1305. PubMed ID: 28236172
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K
Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470
[TBL] [Abstract][Full Text] [Related]
6. Prediction of B cell and T cell epitopes of DBLalpha domain in Plasmodium falciparum malaria vaccine candidate var gene.
Ozarkar AD; Prakash D; Deobagkar DN; Deobagkar DD
Protein Pept Lett; 2007; 14(6):528-30. PubMed ID: 17627591
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the immunogenicity and vaccine potential of recombinant Plasmodium falciparum merozoite surface protein 8.
Alaro JR; Angov E; Lopez AM; Zhou H; Long CA; Burns JM
Infect Immun; 2012 Jul; 80(7):2473-84. PubMed ID: 22585960
[TBL] [Abstract][Full Text] [Related]
8. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K
J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327
[TBL] [Abstract][Full Text] [Related]
9. In silico analysis and prediction of immunogenic epitopes for pre-erythrocytic proteins of the deadly Plasmodium falciparum.
Asghari A; Nourmohammadi H; Majidiani H; Shariatzadeh SA; Shams M; Montazeri F
Infect Genet Evol; 2021 Sep; 93():104985. PubMed ID: 34214673
[TBL] [Abstract][Full Text] [Related]
10. Malaria vaccine based on self-assembling protein nanoparticles.
Burkhard P; Lanar DE
Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
12. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice.
Perlaza BL; Sauzet JP; Balde AT; Brahimi K; Tall A; Corradin G; Druilhe P
Eur J Immunol; 2001 Jul; 31(7):2200-9. PubMed ID: 11449374
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
[TBL] [Abstract][Full Text] [Related]
14. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
[TBL] [Abstract][Full Text] [Related]
15. Antibodies and Plasmodium falciparum merozoites.
Ramasamy R; Ramasamy M; Yasawardena S
Trends Parasitol; 2001 Apr; 17(4):194-7. PubMed ID: 11282510
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Review of Human
Heide J; Vaughan KC; Sette A; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2019; 10():397. PubMed ID: 30949162
[TBL] [Abstract][Full Text] [Related]
17. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
[TBL] [Abstract][Full Text] [Related]
18. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
[TBL] [Abstract][Full Text] [Related]
19. Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.
Scally SW; Murugan R; Bosch A; Triller G; Costa G; Mordmüller B; Kremsner PG; Sim BKL; Hoffman SL; Levashina EA; Wardemann H; Julien JP
J Exp Med; 2018 Jan; 215(1):63-75. PubMed ID: 29167197
[TBL] [Abstract][Full Text] [Related]
20. Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran.
Zakeri S; Avazalipoor M; Mehrizi AA; Djadid ND; Snounou G
Am J Trop Med Hyg; 2007 Jun; 76(6):1046-51. PubMed ID: 17556609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
